SHENZHEN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- Tongjitang
Chinese Medicines Company (the "Company"; NYSE: TCM), a leading
specialty pharmaceutical company focusing on the development,
manufacturing, marketing and selling of modernized traditional
Chinese medicine in China, today
announced that it plans to release its second quarter 2010
financial results after market close on Wednesday, August 18, 2010.
Tongjitang's management team will hold a conference call on
Thursday, August 19, at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing/Hong
Kong time) following the announcement. Listeners may access
the call by dialing the following numbers:
United States toll free: 1-888-259-8389
Hong Kong toll free: 800-903-658
Northern China toll free: 10-800-714-1504
Southern China toll free: 10-800-140-1379
International: 1-913-312-1483
Listeners may access the replay from approximately two hours
after the call ends through August 26,
2010 by dialing the following numbers:
United States toll free: 1-888-203-1112
International: 1-719-457-0820
Password: 6642433
An audio webcast of the call will also be available through the
Company's website at http://www.tongjitang.com .
About Tongjitang Chinese Medicines Company
Tongjitang Chinese Medicines Company, through its operating
subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution,
Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company
Limited, Qinghai Pulante and Anhui Jingfang, is a vertically
integrated specialty pharmaceutical company focused on the
development, manufacturing, marketing and selling of modernized
traditional Chinese medicine in China. Tongjitang's principal executive
offices are located in Shenzhen,
China.
Tongjitang's flagship product, Xianling Gubao, is the leading
traditional Chinese medicine for the treatment of osteoporosis in
China as measured by sales in
Renminbi. In addition to Xianling Gubao, the Company manufactures
and markets 36 other modernized traditional Chinese medicine
products and 36 western medicines. Please visit
http://www.tongjitang.com for more information.
For more information, please contact:
ICR, LLC
Ashley M. Ammon or Christine Duan
Tel: +1-203-682-8200 (Investor Relations)
SOURCE Tongjitang Chinese Medicines Company
Copyright . 11 PR Newswire